TrialInternational journal of chronic obstructive pulmonary disease2014

Risk of pneumonia with inhaled corticosteroid/long-acting β2 agonist therapy in chronic obstructive pulmonary disease: a cluster analysis.

Rachael L DiSantostefano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.